Clinical Trials : Fibrodysplasia Ossificans Progressiva

Active, not recruiting

Study Name: A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
Condition: Fibrodysplasia Ossificans Progressiva
Date: 2014-12-08

Suspended

Study Name: In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Date: 2015-08-06
Interventions: Drug: Palovarotene Palovarotene will be taken orally once daily at approximately the same time each day.

Active, not recruiting

Study Name: An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Date: 2014-10-26
Interventions:

Drug: Palovarotene dose level 1

Active, not recruiting

Study Name: An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Date: 2014-07-13
Interventions:

Drug: Palovarotene Palovaroten

Completed

Study Name: Urine Sample Collection From FOP Patients
Condition: Fibrodysplasia Ossificans Progressiva
Date: 2014-02-05

Active, not recruiting

Study Name: An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France
Condition: Fibrodysplasia Ossificans Progressiva
Date: 2016-11-23
Interventions:

Drug: Palovarotene dose level 1

COMPLETED

Study Name: A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Condition: Fibrodysplasia Ossificans Progressiva (FOP)
Date: 2025-01-16
Interventions: No study treatment will be administered on this study.

Search for Clinical Trial Results

Fibrodysplasia Ossificans Progressiva - 7 Studies Found

Status	Study
Active, not recruiting	Study Name: A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP) Condition: Fibrodysplasia Ossificans Progressiva Date: 2014-12-08
Suspended	Study Name: In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects Condition: Fibrodysplasia Ossificans Progressiva Date: 2015-08-06 Interventions: Drug: Palovarotene Palovarotene will be taken orally once daily at approximately the same time each day.
Active, not recruiting	Study Name: An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects Condition: Fibrodysplasia Ossificans Progressiva Date: 2014-10-26 Interventions: Drug: Palovarotene dose level 1
Active, not recruiting	Study Name: An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects Condition: Fibrodysplasia Ossificans Progressiva Date: 2014-07-13 Interventions: Drug: Palovarotene Palovaroten
Completed	Study Name: Urine Sample Collection From FOP Patients Condition: Fibrodysplasia Ossificans Progressiva Date: 2014-02-05
Active, not recruiting	Study Name: An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France Condition: Fibrodysplasia Ossificans Progressiva Date: 2016-11-23 Interventions: Drug: Palovarotene dose level 1
COMPLETED	Study Name: A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP) Condition: Fibrodysplasia Ossificans Progressiva (FOP) Date: 2025-01-16 Interventions: No study treatment will be administered on this study.